Medadvisor Ltd Capital Reinvestment Ratio

Latest as of December 2023: 0.07x

Medadvisor Ltd capital reinvestment ratio. Medadvisor Ltd (MDR) has a Capital Reinvestment Ratio of 0.07x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$11.04 Million) in capital expenditures (AU$821.44K). See how much free cash does Medadvisor Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

AU$11.04 Million

AUD

Capital Expenditures

AU$821.44K

AUD

Data as of

Dec 2023

Most recent filing

Capital Reinvestment Ratio of Medadvisor Ltd (2024–2024)

Capital reinvestment ratio of Medadvisor Ltd from 2024 to 2024. This chart tracks Medadvisor Ltd's Capital Reinvestment Ratio across 1 annual periods. See MDR financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Medadvisor Ltd Capital Reinvestment Ratio by Year (2024–2024)

Medadvisor Ltd capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see MDR cash flow conversion.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.35x	AU$5.19 Million	AU$1.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow